5. Cloning and Regenerative Medicine

Cloning and regenerative medicine aim to regenerate tissues and organs, potentially preventing death from organ failure. Stem cell therapy is already in clinical trials, and lab-grown organs are a future goal. Recent advancements include generating humanized organs within animal models, such as the creation of a humanized mesonephros in pig fetuses using human-induced pluripotent stem cells (iPSCs). (nature.com) Additionally, bioengineered 3D integumentary organ systems have been developed from iPSCs, demonstrating the potential for creating complex tissue structures. (nature.com) These developments highlight the progress toward regenerative therapies that could address organ shortages and improve patient outcomes.